Sci Simple

New Science Research Articles Everyday

# Health Sciences # Health Systems and Quality Improvement

Heart Transplant Patients Speak Out on EMBs

Patients share their thoughts on heart monitoring methods and preferences.

Hyoungmin Kim, Vincenzo Cusi, Melissa McLenon, Rebecca Fielding-Miller, Jose Benjamin Cruz Rodriguez, Jennifer Chak, Marcus Anthony Urey, Paul J. Kim

― 7 min read


Patients on Heart Health Patients on Heart Health Monitoring preferences and care experiences. Heart transplant patients discuss test
Table of Contents

Heart Transplants happen when a person's heart needs a replacement due to severe damage or disease. After getting a new heart, patients must undergo regular tests to ensure their new heart is healthy and working properly. One common method to check for any problems is a procedure called an endomyocardial biopsy (EMB). While this procedure is useful, it involves some risks and can make patients feel anxious. In recent times, there has been talk about using less invasive methods, like blood tests that track specific DNA from the donor.

The aim of this study is to check how heart transplant patients feel about these invasive and noninvasive methods. Through discussions with patients and medical staff, researchers want to get a clear picture of their experiences, concerns, and suggestions for better care.

What is Heart Transplant?

Heart transplant is a major operation where a damaged heart is replaced with a healthy heart from a donor. It offers people with severe heart issues a second chance. After surgery, patients are closely monitored to ensure their new heart works well and there are no signs of rejection—that is, the body trying to fight off the new heart.

What Happens After a Heart Transplant?

In the weeks and months following a transplant, doctors keep a close eye on patients. One of the most used methods for checking the heart's health is through EMBs, where doctors take small samples of the heart tissue for testing. However, this method isn't without its challenges. Patients can experience pain, anxiety, and complications during this procedure.

The Challenges of Embs

Endomyocardial Biopsies involve inserting a thin tube into a blood vessel to reach the heart. As you might guess, this isn't exactly a walk in the park. There can be risks like bleeding or heart valve injury. Each procedure can build up stress and discomfort for patients. Because of these concerns, healthcare providers are exploring ways to monitor heart health without needing to do EMBs so often.

New Methods Under Discussion

Researchers are looking into using donor-derived cell-free DNA (dd-cfDNA) and circulating microRNAs instead. These are fancy terms for testing pieces of DNA and tiny RNA molecules in the blood. The idea is to find out if these tests can effectively spot problems without the pain of an EMB.

The Study's Goals

The heart of this study lies in understanding how patients feel about EMBs versus these newer, less invasive tests. Researchers want to know if patients would support changing hospital policies to rely more on these blood tests and less on EMBs. By getting feedback directly from patients, the aim is to shape future medical practices.

How the Study Was Conducted

A mix of methods was used in this study. Researchers interviewed heart transplant patients and conducted surveys to gather Patient Experiences about EMBs. They also talked with nurses, doctors, and other medical staff about their views on EMBs and the new methods.

Recruitment of Participants

To gather this information, researchers brought together a variety of heart transplant patients who recently underwent EMBs. They invited patients to share their thoughts through interviews and surveys. To make it fun, those who participated also had a chance to win a gift card. Researchers also chatted with medical team members about their experiences with EMBs.

Conducting Interviews

Interviews were held either in-person or over the phone. Researchers asked patients about their feelings regarding EMBs and what could be improved. They recorded the conversations to capture all the details accurately. These recordings helped researchers understand the common themes that emerged from patient discussions.

Key Themes Identified

Through the feedback they collected, researchers found three big ideas that repeatedly came up in conversations with patients about EMBs.

1. Alleviating Anxiety

Many patients shared that they felt anxious before and during EMBs. It’s completely normal to feel nervous about anything involving needles and heart surgery! However, many of them reported that their anxiety lessened with each subsequent EMB. Interestingly, most patients described the pain they felt during the procedure as mild, rating it a mere 3.2 on a scale of 0 to 10.

Patients also had some great suggestions for reducing their anxiety during these procedures. They mentioned wanting to listen to their favorite music while the procedure happened. After all, who wouldn’t want to jam out while undergoing a medical procedure? Other suggestions included using numbing cream before injections and being given more information about what would happen during the procedure.

2. Communication is Key

Effective communication between patients and their medical teams was another important theme. Patients mentioned that knowing what to expect helped ease their nerves. Feeling like they were a part of the process was essential to their comfort. They appreciated when doctors and nurses took the time to explain things and answer their questions.

One patient even highlighted that when medical teams introduced themselves at the start, it created a sense of camaraderie. When team members openly communicated about test results and what came next, patients felt more cared for and less anxious.

3. Building Trust

The final major theme focused on the strong bond between patients and their heart transplant team. Patients expressed feelings of trust towards their doctors and nurses. Even when they faced unpleasant experiences during EMBs, many stated that they felt grateful for the overall care they received.

Interestingly, despite some discomfort linked to EMBs, many patients were open to changing their EMB frequency if their doctor recommended shifts toward noninvasive alternatives. This shows a high level of trust, as patients were willing to go with their team's advice.

Perspectives from the Heart Transplant Team

Medical staff also shared their insights during the study. They were in favor of the suggestions made by patients to improve the EMB experience. Staff members discussed ways to ensure that patients remained comfortable during the procedures, like using smaller drapes that keep them connected to the process.

While many healthcare providers were in favor of reducing the frequency of EMBs, they also raised questions about the need for more research to confidently make those changes. This reflects a balanced approach to patient health—wanting to provide care while ensuring the best outcomes.

The Importance of Trust in Patient Care

The study revealed that trust plays a vital role in patient experiences. Patients showed they were comfortable with their team and appreciated the care they received. By understanding that patients felt a connection with their nurses and doctors, the healthcare system can focus on building stronger relationships, which could enhance overall care.

Patients' Willingness to Accept Recommendations

Patients in the study showed that they were open to recommendations from their medical teams. This is a valuable finding, as it shows that when patients have trust in their providers, they are more likely to accept changes in their care, including moving away from more invasive procedures like EMBs.

Limitations of the Study

While the study provided many insights, there were some limitations to consider. The research was conducted at a single medical center, which may not fully capture the experiences of heart transplant patients everywhere. Additionally, the demographic of the patient pool was fairly homogeneous, mostly consisting of a specific gender and ethnicity.

Furthermore, the study relied on patients' memories and perceptions, which can sometimes lead to biases in their responses. The research team tried to minimize this by conducting interviews close to the time of transplant. Despite these limitations, the findings serve as a stepping stone for future studies exploring the experiences of heart transplant patients.

Conclusion

In summary, this study sheds light on the experiences of heart transplant patients regarding EMBs and their preference for shared decision-making with their medical teams. The insights gained emphasize the importance of reducing patient anxiety, effective communication, and building interpersonal trust.

Heart transplant patients largely trust their healthcare teams and feel comfortable sharing their views on their care. As hospitals consider modifying current practices for monitoring heart health, these patient experiences should play a key role in shaping future decisions.

As we continue to advance in medicine, the voices of patients will remain central in tailoring healthcare to improve their quality of life. Because, at the end of the day, it’s all about making life a little better, one heartbeat at a time.

Original Source

Title: Patient Adapted Paternalism for Endomyocardial Biopsy Policy Changes in Heart Transplant Patients: A Mixed-Methods Study

Abstract: Endomyocardial biopsies (EMB) are invasive procedures performed in heart transplant (HTx) patients for surveillance of acute rejection. However, patient preferences for replacing EMBs with noninvasive assays in the context of potential institutional policy changes are unknown. A mixed-methods design was used with 28 semi-structured patient interviews and 123 self-administered online survey questionnaires in English and Spanish between January to June 2023. Additionally, we performed semi-structured interviews with 18 HTx team members. Three dominant themes were identified: alleviating patient anxiety and distress, consistent patient-provider communication, and strong interpersonal trust with the HTx team. We found that strong interpersonal trust with the HTx team by the patients was more highly prioritized than their own opinions on whether to replace EMBs with noninvasive assays. Thus, HTx patients often considered surveillance EMBs important to their care (93%), based on the recommendations provided by their HTx team. HTx faculty physicians stated that more multicenter trials are needed prior to replacing EMBs with noninvasive assays. In conclusion, patients identified strong interpersonal trust with HTx team members to justify patient adapted paternalism, where the provider decides in accordance with the patients situation, as their preferred shared decision-making paradigm when considering institutional policy on surveillance EMBs.

Authors: Hyoungmin Kim, Vincenzo Cusi, Melissa McLenon, Rebecca Fielding-Miller, Jose Benjamin Cruz Rodriguez, Jennifer Chak, Marcus Anthony Urey, Paul J. Kim

Last Update: 2024-12-30 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.12.29.24319749

Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.29.24319749.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

Similar Articles